Skip to main content

Table 3 Analysis of the risk factors of neonatal hypoglycemia in all cases (n = 603)

From: Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study

 

No Neonatal Hypoglycemia

Neonatal Hypoglycemia

p value

AOR

95%CI

p value

Case (n)

504 (83.6)

99 (16.4)

    

Gestational age (wk/day)

38/5 (36/0 – 41/6)

37/1 (36/0 – 41/2)

< 0.001

0.516

0.366–0.726

< 0.001

Birth weight < 2500 g (n)

57 (11.3)

47 (47.5)

< 0.001

3.484

1.856–6.540

< 0.001

Twin birth (n)

24 (4.8)

30 (30.3)

< 0.001

1.645

0.772–3.505

0.197

Maternal diabetes (n)

21 (4.2)

5 (5.1)

0.598

1.272

0.358–4.521

0.710

Oral administration of RD (n)

68 (13.5)

17 (17.2)

0.344

0.806

0.393–1.654

0.557

Intravenous administration of RD (n)

36 (7.1)

58 (58.6)

< 0.001

6.595

3.307–13.153

< 0.001

  1. Data are expressed as median (min-max) or number (%)
  2. RD Ritodrine hydrochloride, AOR Adjusted odds ratio, CI Confidence interval